-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 27, Baiyunshan issued an announcement stating that its wholly-owned subsidiary Mingxing Pharmaceutical had received the "Notice of Approval of Drug Supplement Application" issued by the State Food and Drug Administration on September 26.
Mingxing Pharmaceutical’s pyrazinamide tablets were officially launched in China in 1982.
Pyrazinamide tablets are anti-tuberculosis drugs and are used in combination with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol) to treat tuberculosis
At present, the manufacturers of pyrazinamide tablets listed in China also include Shenyang Hongqi Pharmaceutical Co.
As of the date of this announcement, Mingxing Pharmaceutical has invested approximately RMB 6.